Notícias

Shares of Wayfair soared Tuesday after the furniture retailer reported better-than-expected second-quarter earnings, with sequential revenue growth at its best level since 2020. The company posted adjusted earnings of 95 cents a share, up from 87 cents a year ago and above Wall Street expectations of 90 cents. Net revenue in the period grew nearly 8% from a year earlier to $3.52 billion, beating the analyst consensus call for $3.47 billion.

Compute margins and lower cash overhead lifted quarterly EBITDA above expectations, but a statewide interconnection audit adds uncertainty to the planned first-quarter 2027 energization of Hut 8’s contracted Texas campus.

Palantir's (PLTR) second quarter earnings results beat Wall Street's estimates. Morning Brief host Julie Hyman chats with Business Insider executive editor Dan DeFrancesco and Yahoo Finance Breaking Business News Reporter Jake Conley about the results and the valuation.

On Tuesday, Voyager Technologies soared after smashing earnings estimates a day earlier. The stock is up roughly 35% this year.

Palantir Technologies Inc (NYSE:PLTR) shares jumped 20% to about $152 in early trade on Tuesday the company reported second quarter 2026 results that exceeded Wall Street expectations for both earnings and revenue. The company reported adjusted earnings per share of $0.41, compared with the...

McDonald’s Corporation (NYSE:MCD) reported second-quarter 2026 results that exceeded Wall Street earnings expectations, although revenue came in slightly below analyst forecasts. The fast-food giant delivered higher profit and positive comparable sales growth across all of its operating segments, helping lift the stock 2.

Snap reported Q2 revenue of $1.6 billion, up 19% year over year, with daily active users reaching 493 million

Higher crack spreads driven by Strait of Hormuz supply disruptions pushed the refiner's quarterly net income to $5.1 billion

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock

PSEG (PEG) delivered earnings and revenue surprises of +7.50% and -5.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ImmunityBio (IBRX) delivered earnings and revenue surprises of +11.11% and +5.76%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Palantir's AI Growth Is Accelerating. Wall Street Just Raised Its Price Target

Qnity Electronics, Inc. (NYSE:Q) reported second-quarter 2026 results that comfortably surpassed Wall Street expectations and raised its financial guidance for the full year, sending the company’s shares 10.

Qnity Electronics beat Wall Street's targets for the second quarter and raised its guidance for the full year. Qnity stock rose.

F's Q2 earnings beat, raised 2026 guidance, improving product mix and narrowing EV losses strengthen its investment case.

Caterpillar Inc (NYSE:CAT, XETRA:CAT) shares jumped 11% to $923 in pre-market trading on Tuesday after booming demand for power-generation equipment helped the industrial group deliver record quarterly revenue. Sales increased 24% to $20.5 billion in the second quarter, beating the $19.3...

Leidos Holdings Inc. (NYSE:LDOS) reported second-quarter 2026 results that comfortably exceeded Wall Street expectations, prompting the defence and technology contractor to raise its financial outlook for the full year.

Bruker (BRKR) delivered earnings and revenue surprises of +28.95% and -2.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Caterpillar Inc. (NYSE:CAT) shares rose more than 5% in pre-market trading after the industrial equipment manufacturer reported second-quarter 2026 results that comfortably exceeded Wall Street expectations, driven by higher equipment demand across its core businesses.

The chipmaker beat analyst estimates on both profit and revenue, and now expects its AI data center business to more than double in 2026

Rising sales of drugs for cancer and heart disease helped offset steep declines for Pfizer’s Covid-19 products.

Caterpillar bulldozed Q2 earnings forecasts as the heavy equipment giant reported a $72 billion backlog, up 92% from a year ago. Long a global economic bellwether, Caterpillar has become a bellwether for the AI infrastructure boom amid soaring demand for its gas turbines to power data centers. The construction segment was Caterpillar's biggest growth driver in Q2, but growth was strong across the board.

US equity futures were higher pre-bell Tuesday as technology-related stocks were on the upswing, hig

Investing.com -- Wayfair shares slipped about 3% in premarket trading Tuesday despite the online furniture retailer posting second-quarter results ahead of expectations on both revenue and earnings.

Merck (MRK) delivered earnings and revenue surprises of +50.00% and +1.69%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The drugmaker posted adjusted earnings of 77 cents per share and now expects full-year revenue of $60.5 billion to $62.5 billion

U.S. optical component stocks surged following a Reuters report that the Trump administration is drafting a ban on U.S. imports of new Chinese data center hardware. Applied Optoelectronics jumped 16%, Coherent gained 13%, Lumentum rose 11%, and Corning climbed 8%. According to four sources familiar with the matter, the Federal Communications Commission (FCC) is preparing restrictions against new Chinese optical transceivers—the critical hardware that routes data over fiber-optic cables inside AI

Investing.com -- Caterpillar Inc. (NYSE: CAT) reported second-quarter results before the open on Tuesday, exceeding analyst expectations and sending its stock higher in premarket trading.

Investing.com -- Merck reported significantly better-than-expected earnings for the second quarter, while narrowing and raising its full-year revenue outlook.

(Bloomberg) -- Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share. Now, some see the pharma giant’s stock as primed for a split.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevApple’s New CEO Taps Retired Hardware Executive for Management TeamTaco Bell Met With Michigan on Parasite Weeks Before RecallMamdani Dismisses Business Leaders Advising NYC’s Mayor’s FundS&P 5